Delft breathes knowledge and technology, constantly innovating to create smart solutions for a healthier world.
Proteins of Tomorrow is a start-up that combines food technology and biotechnology to create mycoprotein muscle tissue.
On May 9, 2023, dsm‑firmenich confirmed the successful merger of DSM and Firmenich, and with it the start of a new company developing and producing vital nutrients, flavors and fragrances…
dsm-firmenich is building a new head office on the Biotech Campus Delft for the Taste, Texture & Health business unit.
The dot on the horizon has been set: the ASR Dutch Science Park Fund is investing in the development of Biotech Campus Delft to turn it into an international top…
In 2019, DSM, which became dsm-firmenich on May 9, 2023, opened its site in Delft to other parties in the field of biotechnology.
dsm-firmenich is excited to confirm the successful merger of DSM and Firmenich and the resulting launch of a new company that brings together one of the largest innovation and creation…
Pressrelease Heerlen & Utrecht (NL), 06 April 2023 DSM and ASR Dutch Science Park Fund team up to further develop the Biotech Campus Delft (BCD) to world-leader in bioscience.
Big news: DSM and Firmenich are to merge. This will create a new multinational company with 28. 000 employees and a turnover of more than 11 billion euro.
Healthy food for the whole world: Delft is working on it.